Brii Biosciences Statistics
Total Valuation
BRIBF has a market cap or net worth of 192.51 million. The enterprise value is -106.15 million.
| Market Cap | 192.51M |
| Enterprise Value | -106.15M |
Important Dates
The next estimated earnings date is Friday, November 21, 2025.
| Earnings Date | Nov 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 719.38M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.14% |
| Shares Change (QoQ) | -0.99% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 593.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 47.93 |
| PB Ratio | 0.57 |
| P/TBV Ratio | 0.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 2.02 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 42.98, with a Debt / Equity ratio of 0.00.
| Current Ratio | 42.98 |
| Quick Ratio | 42.68 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -110.62 |
Financial Efficiency
Return on equity (ROE) is -14.42% and return on invested capital (ROIC) is -8.60%.
| Return on Equity (ROE) | -14.42% |
| Return on Assets (ROA) | -8.42% |
| Return on Invested Capital (ROIC) | -8.60% |
| Return on Capital Employed (ROCE) | -14.88% |
| Revenue Per Employee | 41,839 |
| Profits Per Employee | -546,285 |
| Employee Count | 98 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +91.71% in the last 52 weeks. The beta is 1.38, so BRIBF's price volatility has been higher than the market average.
| Beta (5Y) | 1.38 |
| 52-Week Price Change | +91.71% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 29.97 |
| Average Volume (20 Days) | 28,233 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BRIBF had revenue of 4.02 million and -52.44 million in losses. Loss per share was -0.07.
| Revenue | 4.02M |
| Gross Profit | 4.02M |
| Operating Income | -50.60M |
| Pretax Income | -52.76M |
| Net Income | -52.44M |
| EBITDA | -50.46M |
| EBIT | -50.60M |
| Loss Per Share | -0.07 |
Balance Sheet
The company has 289.61 million in cash and 1.03 million in debt, giving a net cash position of 288.58 million.
| Cash & Cash Equivalents | 289.61M |
| Total Debt | 1.03M |
| Net Cash | 288.58M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 339.74M |
| Book Value Per Share | 0.48 |
| Working Capital | 284.84M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,259.84% |
| Pretax Margin | -1,313.65% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BRIBF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.14% |
| Shareholder Yield | n/a |
| Earnings Yield | -27.24% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |